A Post-approval Observational Study to Evaluate the Long-term Effectiveness and Safety of Orkambi in US Patients who Completed Study VX12-809-105 Part A
Research Grant
Administered By
Pediatrics, Pulmonary and Sleep Medicine
Awarded By
Vertex Pharmaceuticals Inc.
Start Date
June 21, 2018
End Date
December 24, 2019
Administered By
Pediatrics, Pulmonary and Sleep Medicine
Awarded By
Vertex Pharmaceuticals Inc.
Start Date
June 21, 2018
End Date
December 24, 2019